Gel based on cubic liquid crystals nanoparticles enhance anti-inflammation and bone protection effects of triptolide
Journal of Drug Delivery Science and Technology, ISSN: 1773-2247, Vol: 72, Page: 103387
2022
- 4Citations
- 9Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Rheumatoid arthritis (RA) is a systemic autoimmune disease which could not only cause inflammatory reaction, but also cause cartilage and bone damage. The clinical treatment is mainly aimed at anti-inflammatory and immunotherapy. Targeting both at inflammation and bone damage repairing will be great significance for RA therapy. Triptolide has high efficiency of anti-inflammatory and anti-immune. And reported it had the effect of bone damage repairing on RA rats. But serious toxicity limits its development and application. In this study we prepared lipid cubic crystal nanoparticles gels of triptolide (TP-LCNPS-GEL) to treat rheumatoid arthritis by transdermal delivery. Temperature sensitivity and microstructure of TP-LCNPS-GEL was characterized. TP-LCNPS-GEL greatly improved percutaneous permeability, prolong biological half-life, average retention time and bioavailability of triptolide. The animal experiment results show that TP-LCNPS-GEL enhanced the effects on anti-inflammatory and bone protection of triptolide with low toxicity. All results indicated that TP-LCNPS-GEL as a transdermal delivery preparation is an excellent choice for rheumatoid arthritis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1773224722002970; http://dx.doi.org/10.1016/j.jddst.2022.103387; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85130224131&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S1773224722002970; https://dx.doi.org/10.1016/j.jddst.2022.103387
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know